LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS
The most prevalent formulation of the low-dosage (ld) acetylsalicylic acid (ASA) for prevention purposes is the gut soluble pill — 80,6% of the ldASA registered in pharmacy market. Formulations of ldASA mostly presented as ASA monodrugs (84,4%), containing only ASA as active substance, predominantly...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2017-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/661 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839577922194636800 |
|---|---|
| author | V. V. Rafalsky A. V. Krikova N. A. Pavlyuchenkova |
| author_facet | V. V. Rafalsky A. V. Krikova N. A. Pavlyuchenkova |
| author_sort | V. V. Rafalsky |
| collection | DOAJ |
| description | The most prevalent formulation of the low-dosage (ld) acetylsalicylic acid (ASA) for prevention purposes is the gut soluble pill — 80,6% of the ldASA registered in pharmacy market. Formulations of ldASA mostly presented as ASA monodrugs (84,4%), containing only ASA as active substance, predominantly as 100 mg dosage. Amount of ASA of 81 mg has become widespread only in North America, that is related to nonmetric measurement system. Combinational ldASA with non-soluble antacide (magnesium hydroxide) are not broadly used throughout the world — 1,6% of all pharmacy market registered labels, and mostly in use in the regions of former USSR. |
| format | Article |
| id | doaj-art-02f859635dcc4d3b9a7f3da7eebd357f |
| institution | Matheson Library |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2017-08-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-02f859635dcc4d3b9a7f3da7eebd357f2025-08-04T12:50:22Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252017-08-01164687510.15829/1728-8800-2017-4-68-75477LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONSV. V. Rafalsky0A. V. Krikova1N. A. Pavlyuchenkova2FSBEI HE “Smolensky State Medical University” of the Ministry of Health; FSAEI HE “Baltiysky Federal University named after Immanuil Kant”FSBEI HE “Smolensky State Medical University” of the Ministry of HealthFSBEI HE “Smolensky State Medical University” of the Ministry of HealthThe most prevalent formulation of the low-dosage (ld) acetylsalicylic acid (ASA) for prevention purposes is the gut soluble pill — 80,6% of the ldASA registered in pharmacy market. Formulations of ldASA mostly presented as ASA monodrugs (84,4%), containing only ASA as active substance, predominantly as 100 mg dosage. Amount of ASA of 81 mg has become widespread only in North America, that is related to nonmetric measurement system. Combinational ldASA with non-soluble antacide (magnesium hydroxide) are not broadly used throughout the world — 1,6% of all pharmacy market registered labels, and mostly in use in the regions of former USSR.https://cardiovascular.elpub.ru/jour/article/view/661acetylsalicylic acidpreventioncardiovascular diseasesdrug formulationsmarketing analysis |
| spellingShingle | V. V. Rafalsky A. V. Krikova N. A. Pavlyuchenkova LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS Кардиоваскулярная терапия и профилактика acetylsalicylic acid prevention cardiovascular diseases drug formulations marketing analysis |
| title | LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS |
| title_full | LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS |
| title_fullStr | LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS |
| title_full_unstemmed | LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS |
| title_short | LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS |
| title_sort | low dosage acetylsalicylic acid a variety of formulations |
| topic | acetylsalicylic acid prevention cardiovascular diseases drug formulations marketing analysis |
| url | https://cardiovascular.elpub.ru/jour/article/view/661 |
| work_keys_str_mv | AT vvrafalsky lowdosageacetylsalicylicacidavarietyofformulations AT avkrikova lowdosageacetylsalicylicacidavarietyofformulations AT napavlyuchenkova lowdosageacetylsalicylicacidavarietyofformulations |